đź§  Parkinson's Digest Give Feedback
  • All
  • Research
  • Trials
  • News
A qPCR-based approach targeting the microbial gene marker nanA of mucin-degrading Akkermansia in Parkinson's disease
News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents Aug. 11, 2026
A Study of NE3107 in Early Parkinson's
Trial Phase 2 Completed Aug. 10, 2026
NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study.
Trial N/A Completed Aug. 10, 2026
Different Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease
Trial N/A Recruiting Aug. 10, 2026
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease
Trial N/A Completed Aug. 10, 2026
SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
Trial N/A Recruiting Aug. 10, 2026
Parkinson’s Passport
News Parkinson's Ireland Aug. 10, 2026
Summer Session Videos
News Parkinson's Ireland Aug. 10, 2026
Ready to use Parkinson’s stem cell therapy put on FDA fast track
News Parkinson's News Today – The Web's Daily Resource for Parkinson's News Aug. 10, 2026
Wicklow Local Sports Partnership
News Parkinson's Ireland Aug. 10, 2026
Trihexyphenidyl hydrochloride for Parkinson’s disease
News Parkinson's News Today – The Web's Daily Resource for Parkinson's News Aug. 10, 2026
Augmented Reality Treadmill Training in Patients With Parkinson's Disease
Trial N/A Terminated Aug. 9, 2026
Effects of Transcranial Pulse Stimulation in Parkinson's Disease
Trial N/A Completed Aug. 9, 2026
Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study
Trial N/A Active, not recruiting Aug. 9, 2026
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
Trial Phase 2 Recruiting Aug. 9, 2026
A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
Trial Phase 1 Recruiting Aug. 9, 2026
5-HT RBD REM Sleep Behavior Disorder
Trial N/A Active, not recruiting Aug. 9, 2026
Imaging Biomarkers of FOG Response to DBS
Trial Phase 4 Recruiting Aug. 9, 2026
Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study
Trial N/A No longer available Aug. 9, 2026
Our Most Successful Webcasts
News Brian Grant Foundation Aug. 7, 2026
Previous Next

Parkinson's Digest provides access to the latest Parkinson's disease news, research, and clinical trials.

Feedback | Privacy Policy | Source Code

Created by Brian Gaudino. Data sourced from ClinicalTrials.gov, PubMed, and other public sources.

Parkinson's Digest is provided for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.

© 2026 Parkinson's Digest